Skip to main content
Subscribe
Register
Sign in
Membership
Events
Knowledge Center
About
Subscribe
Register
Sign in
Stephen Taub
Latest Articles
Biopharma Funds Deliver Market-Beating Returns as Valuations Snap Back
Stephen Taub
December 11, 2025
Tulip Trend and Quantedge Lead November Gains for CTAs
Stephen Taub
December 10, 2025
Premium
Ex-TCI Partner Edgar Allen’s High Ground Racks Up Record Year
Stephen Taub
December 9, 2025
Premium
Renaissance’s Public Funds Stage Double-Digit Comeback in November
Stephen Taub
December 8, 2025
Third Point Inches Lower in November as Magnificent Seven Stumble
Stephen Taub
December 4, 2025
Premium
RA Capital Doubles Down on Private Deals as Year-End Frenzy Builds
Stephen Taub
December 2, 2025
Greenlight Builds Momentum After Summer Losses
Stephen Taub
December 1, 2025
Coatue Joins $2.3 Billion Bet on Hot AI Coding Platform
Stephen Taub
November 26, 2025
Premium
Hedge Funds Cash in on Rare IPO
Stephen Taub
November 25, 2025
Premium
QMS Diversified Global Macro Defied the CTA Trend
Stephen Taub
November 24, 2025
Valiant: ‘Not Only Did the Team Not Waiver — They Doubled Down’
Stephen Taub
November 20, 2025
Stan Druckenmiller Overhauls His Family Office’s U.S. Stock Portfolio
Stephen Taub
November 19, 2025
Premium
Tiger Cubs Pounce: Light Street, D1, Maverick, Viking, and Lone Pine Establish New Positions in Q3
Stephen Taub
November 18, 2025
Premium
Jericho, Whale Rock, Coatue and Other Hedge Funds Embrace Alphabet
Stephen Taub
November 17, 2025
Premium
RTW and Rivals Cash In as Biopharma Roars Back
Stephen Taub
November 13, 2025
Renaissance Suffers Huge Losses in October
Stephen Taub
November 12, 2025
Premium
Private Deals Fuel Viking’s Standout Funds
Stephen Taub
November 11, 2025
Premium
Icahn’s Private Portfolio Lags Market Again, Poised for Another Annual Loss
Stephen Taub
November 10, 2025
More Articles